Stocksigma LogoStocksigma Logo

Vanta Bioscience Reports Turnaround to Profitability in H1 ended Sep'26

Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs

Vanta Bioscience Reports Turnaround to Profitability in H1 ended Sep'26

Vanta Bioscience Ltd 路 Outcome 路 14 Nov 2026, 12:36 am

Vanta Bioscience Reports Turnaround to Profitability in H1 ended Sep'26 Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs. 30.18 lakhs in the half year ended 30th Sep'25. Total revenue stood at Rs. 109.95 lakhs versus Rs. 30.18 lakhs YoY. The company posted a turnaround consolidated net profit of Rs. 5.14 lakhs compared to a net loss of Rs. 181.89 lakhs in the year-ago period. Basic and diluted EPS improved to Rs. 0.07 from a negative Rs. 2.56 YoY.

Original exchange filing (PDF)

More announcements from Vanta Bioscience Ltd

All Vanta Bioscience Ltd announcements